TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · major macro event coming up
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

3.30$ -0.9% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns MiMedx Group Inc (MDXG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.8% of the shares are freely tradable; institutional investors hold 76.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 76.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 78.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 146Mio.

Largest Shareholders

Institutions

Institutions MDXG
Name Stake (%) Shares Change (%) Date
Essex Woodlands Health Ventures 19.32 28,195,249 +0.0 06/30/2026
BlackRock Inc 8.33 12,154,466 +2.0 06/30/2026
Nantahala Capital Management, LLC 6.53 9,535,104 +180.7 06/30/2026
Trigran Investments Inc 4.92 7,173,770 +0.0 06/30/2026
State Street Corp 3.82 5,578,920 +10.3 06/30/2026
Vanguard Capital Management, LLC 3.55 5,187,053 +0.4 06/30/2026
Paradigm Capital Management, Inc. 2.79 4,073,100 +19.4 06/30/2026
Geode Capital Management, LLC 2.15 3,143,488 +9.1 06/30/2026

Funds

Funds MDXG
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.55 3,722,390 +0.0 09/30/2026
iShares Russell 2000 ETF 2.07 3,013,983 -0.4 10/29/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?